Ruboxistaurin
Encyclopedia
Ruboxistaurin is an investigational drug for diabetic peripheral retinopathy. It is currently being investigated by Eli Lilly and Company
.
On February, 2006, Lilly submitted a New Drug Application for ruboxistaurin, and on August 18, 2006, Lilly received an "approvable" letter from the United States
Food and Drug Administration
for ruboxistaurin, with a request for an additional clinical trial, which would take 5 years to complete.
Eli Lilly and Company
Eli Lilly and Company is a global pharmaceutical company. Eli Lilly's global headquarters is located in Indianapolis, Indiana, in the United States...
.
On February, 2006, Lilly submitted a New Drug Application for ruboxistaurin, and on August 18, 2006, Lilly received an "approvable" letter from the United States
United States
The United States of America is a federal constitutional republic comprising fifty states and a federal district...
Food and Drug Administration
Food and Drug Administration
The Food and Drug Administration is an agency of the United States Department of Health and Human Services, one of the United States federal executive departments...
for ruboxistaurin, with a request for an additional clinical trial, which would take 5 years to complete.